Given its importance for FSHD, interfering with DUX4 expression or function has strong therapeutic relevance, and this session highlighted the strategies for blocking DUX4 transcription or inducing DUX4 RNA degradation. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.